149 related articles for article (PubMed ID: 10938961)
21. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety.
Zou S; Fujii K; Johnson S; Spencer B; Washington N; Iv EN; Musavi F; Newman B; Cable R; Rios J; Hillyer KL; Hillyer CD; Dodd RY;
Transfusion; 2006 Nov; 46(11):1997-2003. PubMed ID: 17076856
[TBL] [Abstract][Full Text] [Related]
22. GB virus C/hepatitis G virus infection in Indian blood donors and high-risk groups.
Desai MM; Pal RB; Banker DD
Transfus Apher Sci; 2004 Apr; 30(2):111-7. PubMed ID: 15062748
[TBL] [Abstract][Full Text] [Related]
23. Presence and significance of transfusion-transmitted virus infection in Iranian patients on maintenance hemodialysis.
Kheradpezhouh M; Taremi M; Gachkar L; Aghabozorgi S; Khoshbaten M
J Microbiol Immunol Infect; 2007 Apr; 40(2):106-11. PubMed ID: 17446957
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis G virus (HGV): current perspectives.
Sehgal R; Sharma A
Indian J Pathol Microbiol; 2002 Jan; 45(1):123-8. PubMed ID: 12593580
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components.
Hitzler WE; Runkel S
Clin Lab; 2004; 50(1-2):25-31. PubMed ID: 15000218
[TBL] [Abstract][Full Text] [Related]
27. Transfusion virology: progress and challenges.
Simmonds P
Blood Rev; 1998 Sep; 12(3):171-7. PubMed ID: 9745887
[TBL] [Abstract][Full Text] [Related]
28. Hemophilia therapy and blood-borne pathogen risk.
Knight R; Stanley S; Wong M; Dolan G
Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():3-9. PubMed ID: 16804829
[TBL] [Abstract][Full Text] [Related]
29. SEN virus infection in children in Taiwan: transmission route and role in blood transfusion and liver diseases.
Hsu HY; Ni YH; Chiang CL; Shyu MK; Chen HL; Chang MH
Pediatr Infect Dis J; 2006 May; 25(5):390-4. PubMed ID: 16645500
[TBL] [Abstract][Full Text] [Related]
30. Emergence of new viral infections: implications for the blood supply.
Nathanson N
Biologicals; 1998 Jun; 26(2):77-84. PubMed ID: 9811509
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India.
Chattopadhyay S; Rao S; Das BC; Singh NP; Kar P
Hemodial Int; 2005 Oct; 9(4):362-6. PubMed ID: 16219056
[TBL] [Abstract][Full Text] [Related]
32. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
Polizzotto MN; Wood EM; Ingham H; Keller AJ;
Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
[TBL] [Abstract][Full Text] [Related]
33. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
34. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
35. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB;
Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033
[TBL] [Abstract][Full Text] [Related]
36. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort.
Cannon MJ; Operskalski EA; Mosley JW; Radford K; Dollard SC
J Infect Dis; 2009 Jun; 199(11):1592-8. PubMed ID: 19385734
[TBL] [Abstract][Full Text] [Related]
37. New hepatitis viruses.
Paraná R; Lyra M
Braz J Infect Dis; 2000 Oct; 4(5):214-6. PubMed ID: 11063553
[TBL] [Abstract][Full Text] [Related]
38. Transfusion safety: Where are we today?
Luban NL
Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
[TBL] [Abstract][Full Text] [Related]
39. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
Maresch C; Schluter PJ; Wilson AD; Sleigh A
Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
